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The gene coding for the trans-activating factor (Tax) of the human T-cell leukemia virus, type I (HTLV-I) was mutagenized in vitro using 
oligonucleotide-directed mutagenesis and recombinant DNA techniques. All except one of the mutagenized tax constructs failed to trans-activate 
the HTLV-I LTR in a eukaryotic test system. Moreover, negative Tax mutant Arg-39~Gly was found to be trans-dominant. This observation 
suggests that Tax contains distinct functional domains mediating different interactions of the protein in the process of trans-activation. 
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I. INTRODUCTION 
The human T-cell leukemia virus, type I (HTLV-I) 
encodes a 40-kDa trans-activating factor, termed Tax. 
This protein activates transcription of the HTLV-I 
provirus, but also a multitude of cellular genes, among 
them genes with regulatory functions like IL-2, IL-2R 
and c-los [1-3]. Tax is regarded as the transforming 
agent of HTLV-I, leading to adult r-cell leukemia [4-6]. 
Beyond its intracellular function as a transcriptional 
regulator, extraeellular Tax protein also affects 
lymphoid cells [7]. However, for a long period the mech- 
anism of the protein's action remained poorly under- 
stood. Recent studies using in vitro mutagenesis suggest 
a multidomain structure for Tax [8,9]. In the present 
study, we subjected Tax to mutational analysis includ- 
ing single amino acid substitution i order to illuminate 
structural features underlying the function of Tax as a 
transcriptional trans-activator. 
2. MATERIALS AND METHODS 
2.1. hi vitro mutagenization f tax 
Mutagenizattion f tax (Fig. 1) was perf'ormed using pHTLV-ta~. 
a plasmid containing the Tax.coding region under control of the 
HTLV-I LTR [5]. Deletion mutant 285-353 was censtructed by clon- 
ing an amber stop oligonucleotide (5'-CTAGTCTAGACTAG-Y) into 
a Stul restriction site of pHTLV-tax. BLV/HTLV.I hybrid Tax was 
made by exchanging the Ncol-Clal restriction fragment of HTLV-I 
tax coding for amino acids 1-59 for the sequence ncoding amino 
acids 1.-26 of BLV Tax. For oligonucleotide-directed mutagenesis. 
Abbreviations: BLV, bovine leukemia virus; CAT, chloramphenicol- 
acctyltransferase; CMV, cytomegalovirus; HTLV, human T-cell leu- 
kemia virus; LTR, long termi,~al repeat; Tax, trans.activating factor: 
tax, gene coding for Tax; TRE. Tax-responsive element 
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appropriate gene fragments were cloned into E. coli phage M 13 mpl 8. 
Using tolg- dltl- E. coli strain CJ 236 for template preparation, ef- 
ficiency of mutagenesis was 70-90% [10]. Point mutations were con- 
firmed by DNA sequence analysis. 
2.2. Cell cuhure and transfi, ction 
HeLa cells were grown in Dulbecco modified Eagle's medium 
supplemented with 5% fetal calf serum (Gibeo). Cell transfection was 
done with DNA calcium phosphate copreeipitates in 60-mm Petri 
dishes. Carrier DNA was added to a final amount of 17/..tg per dish. 
Cell extracts were prepared 48-h post-transfection [I 1]. 
2.4. CA T assay and Western blot analysis 
For CAT assays, tax constructs were co-transfected with reporter 
plasmid pU3RCAT, carrying the chloramphenicol-acetyltransferase 
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Fig. I. In vitro mutagenization f HTLV-I Tax. (a) Wild.type Tax. (b) 
C-terminal deletion: an amber stop oligonucleotide (5'-CTAGTCTA- 
GACTAG-3') was inserted into a Stul site of tax at amino acid 285. 
(c) BLV/HTLV-I hybrid Tax contains amino acids 1.-26 of BLV Tax 
(black area) and residues 60-353 of HTLV.I Tax (white area). (d) 
Point mutations introduced into tile N-temfinal region of Tax. 
210 Published b)' Elsev{er Soil, tree Publishers B. it. 
Volume 292, number 1,2 FEBS LE'I'rERS November 1991 
gene under control of the HTLV-I LTR [12]. CAT assays were per- 
formed e.s described in [I 1]. 
For Western blots, HeLa cell extracts were separated by discon- 
tinuous SDS-PAGE on a 10% gel and transferred onto a lmmobilon 
(Millipore) membrane. Immunoblots were carried out using the Pro- 
toBIot Western blot system (Promega). Primary antibody from rabbit 
directed against he C terminus of Tax was kindly provided by Dr 
Peter Beimling [13]. 
3. RESULTS AND DISCUSSION 
In the present study, we have mutagenized HTLV- I  
Tax using three approaches (Fig. 1). First we removed 
20% of the protein's sequence from the C terminus, 
second we replaced 59 amino acids from the N terminus 
by the first 26 residues of  BLV Tax, and third we per- 
formed site-directed, single amino acid substitutions at 
the N terminus. The ability of  these mutants to trans- 
activate the HTLV- I  LTR was tested in transient chlo- 
ramphenicol-acetyltransferase (CAT) assays. The pres- 
ence of inactive mutant Tax in cell extracts was con- 
firmed by Western blot analysis. 
Our first approach was to reveal whether the C 
terminus of Tax  carries essential functions for trans- 
activation. Other authors found that minor deletions of  
up to 22 amino acids at the C terminus did not abrogate 
completely the protein's activity [9]. We deleted 69 
amino acids f rom the C terminus by cloning an amber 
stop oligonucleotide into a Stu I  restriction site of tax. 
In a transient co-transfection assay, this construct was 
found to be unable of  trans,act ivat ing the HTLV- I  L'I'R 
in HeLa cells (Fig. 2a). Therefore we suppose the region 
between residues 285 and 330 to be essential for trans- 
activation. 
Tax is a potent transcriptional trans-act ivator found 
in HTLV-I,  HTLV- I I  and BLV. A sequence compa- 
rison of  tax products from different sources reveals that 
the N terminus is the most conserved region of the 
protein, indicating that this region supplies the struc- 
tural basis for key functions o f  Tax. This notion is 
supported by our observation that exchange of  the 59 
N-terminal a~,no  acid residues of  HTLV-I  Tax for the 
26 N-terminal residues of BLV Tax results in a complete 
loss of  its in vivo function (Fig. 2a). Moreover, single 
amino acid substitutions at distinct sites in the N ter- 
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Fig. 2. CAT assay of mutagenized tax constructs, tax Constructs were co-transfeeted with reporter plasmid pU3RCAT into HeLa cells in a 60-rnm 
Petri dish. Cells were collected 48 h post-transfection. (a) 2 pg ot' pHTLV-tax plasmid (tax under control of HTLV-I LTR) carrying the indicated 
mutation, were co.transfccted with 3/ag pU3RCAT (lanes 3-10). Lane 2, 2/ag wild-type pHTLV-tax + 3,ug pU3RCAT (positive control). Lane 
1, 3/.~g pU3RCAT (negative control). (b) Wild-type and mutant pC-tax plas,nid (tax under control or CMV promoter) were co-transfected with 
3 #g pU3KCA 1' (la~,,.s 1-8). in addition to 0.2/ag wild-type pC-tax (lanes 2~.8). 
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minus had the same effect. We supposed residues Cys- 
29, Arg-39, Cys-49 and Trp-56 to be essential for t rans-  
activity, as they are conserved in the same positions 
among HTLV-I, HTLV-I I  and BLV. We performed 
oligonucleotide-directed mutagenesis at these sites, sub- 
stituting residue Cys-29 and Arg-39 for glycine, Cys-49 
for tryptophane and Trp-56 for arginine. Any of  these 
substitutions rendered the protein practically inactive. 
The same could be observed on substitution of Tyr-18 
for asparagine (Fig. 2a). Several authors found that Tax 
does not show direct DNA binding activity. However, 
a series of  cellular proteins could be shown to interact 
with Taxoresponsive elements (TREs). Further to this, 
Marriott et al. demonstrated indirect DNA binding of 
Tax via protein-protein teraction with a 36 kDa cel- 
lular TRE binding factor [14]. Therefore, Tax is thought 
to form a complex with cellular transcription factors 
[14-19]. Beyond this, Tax has been shown to bind to a 
zinc affinity column [20]. Evidently, as any action of Tax 
seems to be mediated by intermolecular interactions, 
even the loss of a single functional group may inactivate 
the protein. However, exchange of Ala-47 for glycine 
had no detectable consequence (Fig. 2a). To make sure 
that reduced CAT activity is not the result of  failure to 
express mutagenized tax  constructs, presence of mutant 
Tax in extracts ot" transfected HeLa cells was confirmed 
by Western-blot analysis (data not shown). 
In a further approach, we raised the question whether 
mutant tax  product will show any interference with 
wild-type Tax, if the two proteins are expressed together 
in a eukaryotic in vivo test system, In a transient co- 
transfection assay, we introduced plasmids coding for 
mutant Arg-39---)Gly and wild-type Tax together with 
the reporter plasmid pU3RCAT into HeLa cells. In 
order to avoid effects resulting from different amounts 
of  TREs in the test system, we used tax constructs under 
control of  CMV promoter for this CAT assay. Surpris- 
ingly, when given in excess mutant Tax seemed to di- 
minish wild-type Tax activity (Fig. 2b). With the same 
amount of  wild-type Tax, CAT activity was not 
decreased. Therefore, an unspecific effect of the added 
DNA cannot be the explanation for the drop in t rans .  
activation caused by the mutant. We assume that the 
substitution Arg-39---)Gly destroyed a necessary site for 
the function of Tax (e.g. a transcription factor binding 
site), but left other functionally essential regions of  the 
protein intact. Thus, mutant Tax may be able to form 
inactive partial t rans -act ivat ion  complexes that compete 
with the active, wild-type Tax containing complex for 
binding sites in the target sequence or, alternatively, 
mutant Tax may compete with wild-type Tax for com- 
plex formation with a rate-limiting cellular transcrip- 
tion factor, 
Further to mutant Arg-39~Gly,  we have preliminary 
data suggesting also other Tax mutants to be t rans .  
dominant. We feel that a further investigation of this 
effect may help to identify sequence motifs or domains 
of Tax carrying distinct functions. Beyond this, t rans-  
dominant mutants may also be hopeful candidates for 
an anti-viral agent, particularly as Tax seems to be 
released from HTLV-I-infected cells and affects un- 
infected lymphocytes [7]. 
During our work on this project, Smith and Greene 
published a paper analyzing HTLV-I  Tax by oligonu- 
cleotide-directed mutagenesis [9]. Their findings show 
good accordance with the results presented in this study. 
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